Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that valuations remain high. He advises investors to adopt an active strategy, selecting individual growth-oriented stocks instead of relying on index funds.
Copyright 2024 – Finance News Network
13 Mar 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO, Dr Michael Baker talks 1H20 results progress with the company's lead product Zolpimist, the spay version of Sanofi’s blockbuster insomnia drug Ambien and focus for 2020.
04 May 2023 - Phil Hoskins, Managing Director of Evolution Energy Minerals (ASX:EV1), discusses EV1's Tanzanian Graphite project, the recent updated DFS and the formal signing of framework agreement with the Tanzanian Government.
21 Oct 2019 - Kingston Resources Limited (ASX:KSN) CFO, Chris Drew, provides an update on the company's Misima and Livingstone gold projects and drill program.
08 Dec 2023 - Stealth Global Holdings reports record FY23 results, driven by efficient consolidation, organic growth, and prudent financial management. CEO Mike Arnold reveals plans for further expansion, M&A, and a commitment to dividends in FY24.
10 Jan 2020 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, discusses funding for the Novatti's banking subsidiary, its banking licences and its core customer acquisition proposition.
17 Sep 2019 - Tinybeans Limited (ASX:TNY) Founder & CEO, Eddie Geller discusses the company's FY19 results, growth users to its platform, new services and strategy.
16 Aug 2023 - Tom Spurling - Executive Director - Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
